Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Codexis Inc
CDXSCurrent price
3.65 USD
+0.12 USD (+3.40%)
Last closed
3.56 USD
Company
www.codexis.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
250 479 472 USD
Yield for 12 month
+5.19 %
1Y
3Y
5Y
10Y
15Y
CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California. Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.13 USDP/E ratio
–Dividend Yield
–Current Year
+70 143 000 USD
Last Year
+138 590 000 USD
Current Quarter
+17 073 000 USD
Last Quarter
+26 561 000 USD
Current Year
+51 816 000 USD
Last Year
+100 557 000 USD
Current Quarter
+10 966 000 USD
Last Quarter
+22 483 000 USD
Key Figures CDXS
1 year
3 years
5 years
10 years
EBITDA
-37 792 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-14.65 %
PEG Ratio
-1.16
Return On Equity TTM
-63.45 %
Wall Street Target Price
7.13 USD
Revenue TTM
74 234 000 USD
Book Value
1.12 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
31.5 %
Dividend Yield
–
Gross Profit TTM
20 458 000 USD
Earnings per share
-0.94 USD
Diluted Eps TTM
-0.94 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-87.73 %
Dividend Analytics CDXS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CDXS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CDXS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
138.8889
Enterprise Value Revenue
2.1867
Price Sales TTM
2.8766
Enterprise Value EBITDA
-3.4178
Price Book MRQ
2.3376
Financials CDXS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CDXS
For 52 weeks
1.45 USD
4.91 USD
50 Day MA
3.27 USD
Shares Short Prior Month
2 230 436
200 Day MA
2.86 USD
Short Ratio
5.01
Shares Short
2 102 234
Short Percent
3.39 %
BeatStart